KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Total Liabilities (2016 - 2026)

Teladoc Health's Total Liabilities history spans 14 years, with the latest figure at $1.5 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 27.09% to $1.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 billion, a 27.09% decrease, with the full-year FY2025 number at $1.5 billion, down 27.3% from a year prior.
  • Total Liabilities hit $1.5 billion in Q1 2026 for Teladoc Health, roughly flat from $1.5 billion in the prior quarter.
  • Over the last five years, Total Liabilities for TDOC hit a ceiling of $2.1 billion in Q4 2023 and a floor of $57.7 million in Q2 2022.
  • Historically, Total Liabilities has averaged $1.0 billion across 5 years, with a median of $1.5 billion in 2026.
  • Biggest five-year swings in Total Liabilities: crashed 66.05% in 2024 and later soared 2782.02% in 2025.
  • Tracing TDOC's Total Liabilities over 5 years: stood at $143.8 million in 2022, then soared by 1336.92% to $2.1 billion in 2023, then dropped by 1.98% to $2.0 billion in 2024, then dropped by 27.3% to $1.5 billion in 2025, then dropped by 0.11% to $1.5 billion in 2026.
  • Business Quant data shows Total Liabilities for TDOC at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.